 Email this article to a friend  Printable Version FREE Email Newsletter
(NaturalNews) The European Medicines Agency (EMEA) has reported that two young women died shortly after receiving Merck's Gardasil, a vaccine against several varieties of human papillomavirus (HPV).
Gardasil and Glaxo SmithKline's Cervarix protect against the two strains of HPV that are responsible for 70 percent of cervical cancer cases. Gardasil also protects against two HPV strains that cause 90 percent of genital warts.
The EMEA did not release the names or ages of the women who died, and said the cause of death was still unknown. It described their deaths as "sudden and unexpected."
"In both cases, the cause of death could not be identified. No causal relationship has been established between the deaths of the young women and the administration of Gardasil," the agency said.
The recent deaths mark the fourth and fifth to occur shortly following vaccination with Gardasil and the first in Europe. Previously, three young women, aged 12, 19 and 22, died in the United States within days after receiving a Gardasil shot. In addition, 1,700 cases have been reported of patients suffering non-lethal adverse reactions.
Health officials believe that adverse effects of medication are widely underreported.
Starting in September, the United Kingdom's Department of Health is launching a yearlong campaign to vaccinate British girls between the ages of 11 and 13 with one of the HPV vaccines. The program is expected to prevent 1,000 cervical cancer deaths per year, the department says.
In response to the EMEA's announcement, the Department of Health said it had no plans to reconsider the program or change its advice on vaccination against HPV.
An estimated 1.5 million people in Europe have already received an HPV vaccine.
In the United States, three states have passed laws mandating HPV vaccines for school-age girls, and 38 others have considered similar laws.
Mandatory vaccination has been opposed by the American College of Pediatrics and the New England Journal of Medicine.
Get articles like this delivered to you FREE in our popular email newsletter
|
(FREE) Thursday evening, Nov. 12 at 6pm Pacific (9pm Eastern), call in to hear the NaturalNews Talk Hour with special guest Dr. Caldwell Esselstyn - "Making Yourself Heart Attack Proof" Register via email to receive call-in number:
|
|
Explore NaturalPedia.com, the internet's largest natural health encyclopedia of knowledge, covering over 50,000 topics. It's free!
Visit NaturalPedia.com.
|
 FREE Report: The Five Best Anti-Viral Products to Beat Influenza, Swine Flu, Bird Flu and SARS
• Top anti-viral remedies
• Where to get them now
• Four things to avoid
• Become self-reliant
• Boost your family safety
Click here to read the FREE report now.
|
W.H.O. Declares Global Pandemic
Turn FEAR into Confidence!
Listen to the complete 3.5 hour recording on 4 audio CDs of the Health Ranger's Swine Flu Advanced Preparedness Course, covering natural anti-virals, family safety, infrastructure disruptions, quarantine, preparedness gear and much more.
Testimonials:
"Mike Adams' preparedness course turned our fears into confidence. This is POWERFUL information, coming from a trusted source. If you want to save yourself countless hours researching and getting prepared and if you want to do everything in your power to protect your family, I highly recommend the Health Ranger’s Advanced Preparedness Course."
- N. Nelson (Arizona)
"This is packed information no one should miss."
- T. Valenzuela
"Thanks Mike... during this class you covered prevention and preparedness from A to Z with integrity, brave honesty and outstanding knowledge! Thank you for your steadfast, thorough and cool-headed approach to well being. With deep gratitude for your service." - Bev
Available NOW for immediate shipping.
100% satisfaction guarantee
 NEW Product: Valley of Longevity Shampoo from the Health Ranger
• 98% Organic
• 100% Natural
• 100% Fragrance Free!
• No SLS
• No Parabens
• No synthetic chemicals
• FREE shipping in U.S. on orders over $75
Click here to read more...
|
|
|
Email this article to a friend
Share this article on: 
